Poulton Jeffrey V.
Insider CIK 1782962 · CRVO Director · ALNY EVP, Chief Financial Officer · FIXX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRVO CervoMed Inc. | A Award deriv | 2026-06-08 | 2026-06-10 | 8,150 | — | $0 | 8,150 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 374 | $323.01 | $120.8K | 63,137 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 309 | $321.82 | $99.4K | 63,511 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 230 | $320.81 | $73.8K | 63,820 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 291 | $324.88 | $94.5K | 62,028 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 818 | $323.84 | $264.9K | 62,319 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 223 | $325.67 | $72.6K | 61,805 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 109 | $320.01 | $34.9K | 64,050 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-04 | 2026-03-06 | 114 | $319.03 | $36.4K | 64,159 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2026-03-02 | 2026-03-04 | 10,480 | — | $0 | 10,480 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 454 | $327.67 | $148.8K | 64,939 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 356 | $325.63 | $115.9K | 65,934 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 124 | $324.65 | $40.3K | 66,290 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 65 | $323.62 | $21.0K | 66,414 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2026-03-02 | 2026-03-04 | 4,769 | — | $0 | 66,479 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 541 | $326.81 | $176.8K | 65,393 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 53 | $332.64 | $17.6K | 64,273 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 129 | $331.93 | $42.8K | 64,326 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 112 | $330.85 | $37.1K | 64,455 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 234 | $329.71 | $77.2K | 64,567 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-03-02 | 2026-03-04 | 138 | $328.71 | $45.4K | 64,801 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2026-02-27 | 2026-03-02 | 1,908 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2026-02-27 | 2026-03-02 | 1,908 | — | $0 | 61,710 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-02-13 | 2026-02-17 | 2,242 | $310.08 | $695.2K | 59,802 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2026-02-12 | 2026-02-17 | 4,579 | — | $0 | 62,044 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 27 | $377.82 | $10.2K | 57,465 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 34 | $375.65 | $12.8K | 57,492 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 25 | $374.44 | $9.4K | 57,526 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 6 | $372.46 | $2.2K | 57,551 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 36 | $370.87 | $13.4K | 57,557 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 73 | $369.48 | $27.0K | 57,593 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 170 | $368.62 | $62.7K | 57,666 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 76 | $367.40 | $27.9K | 57,836 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 92 | $366.41 | $33.7K | 57,912 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 405 | $365.56 | $148.1K | 58,004 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 365 | $364.83 | $133.2K | 58,409 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 87 | $363.55 | $31.6K | 58,774 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 135 | $362.38 | $48.9K | 58,861 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 181 | $361.45 | $65.4K | 58,996 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 284 | $360.22 | $102.3K | 59,177 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 156 | $359.14 | $56.0K | 59,461 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 226 | $358.18 | $80.9K | 59,617 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 176 | $357.17 | $62.9K | 59,843 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 76 | $356.09 | $27.1K | 60,019 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 78 | $355.16 | $27.7K | 60,095 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2026-01-12 | 2026-01-14 | 72 | $353.95 | $25.5K | 60,173 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2026-01-11 | 2026-01-14 | 6,193 | — | $0 | 60,245 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 317 | $454.84 | $144.2K | 54,342 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 428 | $453.77 | $194.2K | 54,659 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 869 | $452.69 | $393.4K | 55,087 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 432 | $451.86 | $195.2K | 55,956 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 704 | $450.81 | $317.4K | 56,388 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 324 | $449.79 | $145.7K | 57,092 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 234 | $448.77 | $105.0K | 57,416 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 73 | $447.92 | $32.7K | 57,650 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 4 | $457.64 | $1.8K | 54,052 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 191 | $457.43 | $87.4K | 54,056 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 150 | $446.53 | $67.0K | 57,723 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-10-02 | 2025-10-03 | 95 | $455.82 | $43.3K | 54,247 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-10-01 | 2025-10-03 | 4,644 | — | $0 | 57,873 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-10-01 | 2025-10-03 | 3,108 | — | $0 | 53,229 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 19 | $455.82 | $8.7K | 50,121 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 536 | $452.96 | $242.8K | 51,418 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 886 | $454.04 | $402.3K | 50,532 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 392 | $454.84 | $178.3K | 50,140 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 168 | $451.99 | $75.9K | 51,954 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 63 | $447.98 | $28.2K | 52,332 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 147 | $449.92 | $66.1K | 52,185 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-08-18 | 2025-08-19 | 63 | $450.92 | $28.4K | 52,122 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-08-15 | 2025-08-19 | 4,644 | — | $0 | 52,395 | SEC↗ |
| CRVO CervoMed Inc. | A Award deriv | 2025-06-23 | 2025-06-25 | 8,100 | — | $0 | 8,100 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2025-03-03 | 2025-03-05 | 9,800 | — | $0 | 9,800 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-03-03 | 2025-03-05 | 15,117 | — | $0 | 49,015 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 350 | $242.37 | $84.8K | 48,665 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 382 | $243.36 | $93.0K | 48,283 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 258 | $244.41 | $63.1K | 48,025 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 189 | $245.26 | $46.4K | 47,836 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 77 | $246.18 | $19.0K | 47,759 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 7 | $247.35 | $1.7K | 47,752 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-03-03 | 2025-03-05 | 1 | $248.36 | $248 | 47,751 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 59 | $244.11 | $14.4K | 33,898 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 121 | $243.23 | $29.4K | 33,957 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 300 | $242.44 | $72.7K | 34,078 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 127 | $241.51 | $30.7K | 34,378 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 78 | $240.32 | $18.7K | 34,505 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 35 | $239.18 | $8.4K | 34,583 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 34 | $238.33 | $8.1K | 34,618 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-28 | 2025-03-03 | 42 | $236.51 | $9.9K | 34,652 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-02-27 | 2025-03-03 | 1,908 | — | $0 | 1,908 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-02-27 | 2025-03-03 | 1,908 | — | $0 | 34,694 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 17 | $263.33 | $4.5K | 32,806 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 37 | $261.45 | $9.7K | 32,823 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 30 | $260.57 | $7.8K | 32,860 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 17 | $259.72 | $4.4K | 32,890 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 47 | $258.07 | $12.1K | 32,907 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 37 | $257.51 | $9.5K | 32,954 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 78 | $256.29 | $20.0K | 32,991 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 68 | $255.56 | $17.4K | 33,069 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 160 | $254.35 | $40.7K | 33,137 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 239 | $253.37 | $60.6K | 33,297 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 20 | $264.87 | $5.3K | 32,786 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2025-02-14 | 2025-02-18 | 217 | $252.50 | $54.8K | 33,536 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-02-13 | 2025-02-18 | 3,109 | — | $0 | 33,753 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 945 | $251.42 | $237.6K | 30,741 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 97 | $252.27 | $24.5K | 30,644 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 30 | $247.77 | $7.4K | 32,296 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 246 | $249.60 | $61.4K | 32,050 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-11-26 | 2024-11-27 | 364 | $250.68 | $91.2K | 31,686 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2024-11-25 | 2024-11-27 | 3,434 | — | $0 | 32,326 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 266 | $229.06 | $60.9K | 29,978 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 185 | $234.66 | $43.4K | 29,059 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 115 | $233.53 | $26.9K | 29,244 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 216 | $232.54 | $50.2K | 29,359 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 99 | $231.59 | $22.9K | 29,575 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 304 | $229.93 | $69.9K | 29,674 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 167 | $235.19 | $39.3K | 28,892 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 129 | $228.30 | $29.5K | 30,244 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 34 | $226.82 | $7.7K | 30,373 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 18 | $225.55 | $4.1K | 30,407 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 13 | $224.17 | $2.9K | 30,425 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-26 | 59 | $221.71 | $13.1K | 30,438 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2024-06-24 | 2024-06-26 | 3,278 | — | $0 | 30,497 | SEC↗ |
| CRVO CervoMed Inc. | A Award deriv | 2024-06-14 | 2024-06-14 | 5,750 | — | $0 | 5,750 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2024-03-01 | 2024-03-05 | 15,118 | — | $0 | 15,118 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2024-03-01 | 2024-03-05 | 7,741 | — | $0 | 27,219 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 247 | $154.54 | $38.2K | 19,805 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 194 | $155.45 | $30.2K | 19,611 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 115 | $156.38 | $18.0K | 19,496 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 17 | $157.30 | $2.7K | 19,479 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 1 | $158.09 | $158 | 19,478 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2024-02-27 | 2024-02-29 | 1,908 | — | $0 | 3,816 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2024-02-27 | 2024-02-29 | 1,908 | — | $0 | 20,052 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-16 | 2024-02-20 | 120 | $149.03 | $17.9K | 18,144 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-16 | 2024-02-20 | 369 | $147.50 | $54.4K | 18,782 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-16 | 2024-02-20 | 518 | $148.24 | $76.8K | 18,264 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2024-02-15 | 2024-02-20 | 3,278 | — | $0 | 19,151 | SEC↗ |
| CRVO CervoMed Inc. | A Award deriv | 2023-09-15 | 2023-09-15 | 6,450 | — | $0 | 6,450 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 658 | $184.70 | $121.5K | 18,675 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 1,593 | $185.54 | $295.6K | 17,082 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 944 | $186.39 | $176.0K | 16,138 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 86 | $187.37 | $16.1K | 16,052 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 15 | $188.40 | $2.8K | 16,037 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-08-04 | 2023-08-07 | 164 | $189.31 | $31.0K | 15,873 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2023-08-03 | 2023-08-07 | 3,109 | — | $0 | 19,333 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2023-08-03 | 2023-08-07 | 4,518 | — | $0 | 16,224 | SEC↗ |
| FIXX Homology Medicines, Inc. | A Award deriv | 2023-06-14 | 2023-06-15 | 23,000 | — | $0 | 23,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 81 | $193.18 | $15.6K | 12,602 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 372 | $193.93 | $72.1K | 12,230 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 414 | $194.94 | $80.7K | 11,816 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 42 | $195.65 | $8.2K | 11,774 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-27 | 2023-04-28 | 68 | $197.08 | $13.4K | 11,706 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2023-04-26 | 2023-04-28 | 3,277 | — | $0 | 12,683 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2023-02-27 | 2023-03-01 | 5,724 | — | $0 | 5,724 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2023-02-27 | 2023-03-01 | 11,850 | — | $0 | 11,850 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2022-08-04 | 2022-08-05 | 173 | $210.50 | $36.4K | 9,406 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2022-08-04 | 2022-08-05 | 4,573 | $189.76 | $867.8K | 9,887 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2022-08-04 | 2022-08-05 | 162 | $209.83 | $34.0K | 9,725 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2022-08-04 | 2022-08-05 | 146 | $209.88 | $30.6K | 9,579 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2022-08-03 | 2022-08-05 | 4,518 | — | $0 | 7,653 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2022-08-03 | 2022-08-05 | 3,698 | — | $0 | 11,351 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2022-08-03 | 2022-08-05 | 3,109 | — | $0 | 14,460 | SEC↗ |
| FIXX Homology Medicines, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 18,000 | — | $0 | 18,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2022-02-23 | 2022-02-25 | 18,413 | — | $0 | 18,413 | SEC↗ |
| FIXX Homology Medicines, Inc. | A Award deriv | 2021-06-17 | 2021-06-22 | 18,000 | — | $0 | 18,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-04-20 | 2021-04-21 | 1,333 | $131.75 | $175.6K | 3,185 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-04-20 | 2021-04-21 | 50 | $134.49 | $6.7K | 3,135 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2021-04-19 | 2021-04-21 | 4,518 | — | $0 | 4,518 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2021-02-24 | 2021-02-26 | 23,200 | — | $0 | 23,200 | SEC↗ |
| FIXX Homology Medicines, Inc. | A Award deriv | 2020-07-21 | 2020-07-21 | 36,000 | — | $0 | 36,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2020-02-26 | 2020-02-28 | 24,554 | $118.05 | $2.90M | 24,554 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2020-01-03 | 2020-02-28 | 19 | — | $0 | 19 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2019-10-10 | 2021-04-21 | 38 | — | $0 | 38 | SEC↗ |